Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 16 AL 30

Alzheimer's Disease-Biochemical and Psychological Background for Diagnosis and Treatment

Beata BK, Wojciech J, Johannes K, Piotr L, Barbara M.

Int J Mol Sci. 2023 Jan 5;24(2):1059. doi: 10.3390/ijms24021059.

[General aspects of dementia disorders]

Zieschang T, Schütze S.

Inn Med (Heidelb). 2023 Feb;64(2):127-130. doi: 10.1007/s00108-022-01462-1. Epub 2023 Jan 24.

A Review on the Natural Components Applied as Lead Compounds for Potential Multi-target Anti-AD Theranostic Agents

Kou X, Shi X, Pang Z, Yang A, Shen R, Zhao L.

Curr Med Chem. 2023;30(40):4586-4604. doi: 10.2174/0929867330666230125153027.

Applications of generative adversarial networks in neuroimaging and clinical neuroscience

Wang R, Bashyam V, Yang Z, Yu F, Tassopoulou V, Chintapalli SS, Skampardoni I, Sreepada LP, Sahoo D, Nikita K, Abdulkadir A, Wen J, Davatzikos C.

Neuroimage. 2023 Apr 1;269:119898. doi: 10.1016/j.neuroimage.2023.119898. Epub 2023 Jan 24.

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders

Lanctôt KL, Ismail Z, Bawa KK, Cummings JL, Husain M, Mortby ME, Robert P.

Int J Geriatr Psychiatry. 2023 Feb;38(2):e5882. doi: 10.1002/gps.5882.

Deep neural network heatmaps capture Alzheimer's disease patterns reported in a large meta-analysis of neuroimaging studies

Wang D, Honnorat N, Fox PT, Ritter K, Eickhoff SB, Seshadri S; Alzheimer’s Disease Neuroimaging Initiative; Habes M.

Neuroimage. 2023 Apr 1;269:119929. doi: 10.1016/j.neuroimage.2023.119929. Epub 2023 Feb 4.

Interest of eye movement study in early diagnosis of posterior cortical atrophy: A case-report

Pin G, Trompette C, Ceccaldi M, Felician O, Koric L.

Rev Neurol (Paris). 2023 Mar;179(3):246-248. doi: 10.1016/j.neurol.2022.10.007. Epub 2023 Feb 6.

Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study

Agger MP, Danielsen ER, Carstensen MS, Nguyen NM, Horning M, Henney MA, Jensen CBR, Baandrup AO, Kjær TW, Madsen KH, Miskowiak K, Petersen PM, Høgh P.

J Alzheimers Dis. 2023;92(2):653-665. doi: 10.3233/JAD-221238.

Young-onset dementia diagnosis, management and care: a narrative review

Loi SM, Cations M, Velakoulis D.

Med J Aust. 2023 Mar 6;218(4):182-189. doi: 10.5694/mja2.51849. Epub 2023 Feb 19.

Neuroimaging studies of acupuncture on Alzheimer's disease: a systematic review

Yin Z, Wang Z, Li Y, Zhou J, Chen Z, Xia M, Zhang X, Wu J, Zhao L, Liang F.

BMC Complement Med Ther. 2023 Feb 23;23(1):63. doi: 10.1186/s12906-023-03888-y.

Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance

Hnilicova P, Kantorova E, Sutovsky S, Grofik M, Zelenak K, Kurca E, Zilka N, Parvanovova P, Kolisek M.

Int J Mol Sci. 2023 Feb 7;24(4):3325. doi: 10.3390/ijms24043325.

FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective

Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H.

Eur J Nucl Med Mol Imaging. 2023 May;50(6):1553-1555. doi: 10.1007/s00259-023-06177-5.

Apathy in Alzheimer's disease: A neurocircuitry based perspective

Mehak SF, Shivakumar AB, Saraf V, Johansson M, Gangadharan G.

Ageing Res Rev. 2023 Jun;87:101891. doi: 10.1016/j.arr.2023.101891. Epub 2023 Mar 5.

Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort

Loreto F, Gontsarova A, Scott G, Patel N, Win Z, Carswell C, Perry R, Malhotra P.

Ann Clin Transl Neurol. 2023 Apr;10(4):619-631. doi: 10.1002/acn3.51749. Epub 2023 Mar 5.

Imaging Amyloid-β Membrane Interactions: Ion-Channel Pores and Lipid-Bilayer Permeability in Alzheimer's Disease

Viles JH.

Angew Chem Int Ed Engl. 2023 Jun 19;62(25):e202215785. doi: 10.1002/anie.202215785. Epub 2023 Mar 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias